What Drives Thrombogenesis Despite Antiplatelet Therapy in Diabetes Mellitus?

Diabetes and Vascular Disease Research - United Kingdom
doi 10.1177/1479164110388196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Mechanisms of Thrombogenesis Associated With Diabetes Mellitus: What Defines the Prognosis of Invasive Myocardial Revascularization Methods?

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Glibenclamide Therapy in Diabetes Mellitus

BMJ
1970English

Combined Therapy of Diabetes Mellitus

BMJ
1963English

Stem Cell Therapy in Diabetes Mellitus: Current Trends

International Journal of Biomedical Research
2012English

Pdb124 - Personalized Diabetes Management: What Do Patients With Diabetes Mellitus Prefer?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

New Directions in Antiplatelet Therapy

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Antioxidants (Alpha-Tocoferol Acetate) in Therapy of Diabetes Mellitus

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1993English

Very Late Drug-Eluting Stent Thrombosis After Nonsteroidal Anti-Inflammatory Drug Treatment Despite Dual Antiplatelet Therapy

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Prospects of Antigen-Specific Therapy in Type 1 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy